Moleculin Biotech, Inc. (MBRX) has 23 open-market insider trades by 13 insiders since 2006. The most active filer is Walter V. Klemp, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Suisse/ Credit | 10% | — | 2 | $4.2M | 2008-04-16 |
| Arnold L. Oronsky | Dir10% | — | 1 | $2.3M | 2008-04-16 |
| Philip T. Gianos | 10% | — | 1 | $2.3M | 2008-04-16 |
| Walter V. Klemp | CEOPres | — | 7 | $1.2M | 2026-06-22 |
| Harvey B. Cash | 10% | — | 1 | $401K | 2006-05-22 |
| Jonathan P. Foster | CFO | — | 3 | $229K | 2026-08-03 |
| Waldemar Priebe | 10% Owner | — | 1 | $170K | 2017-08-16 |
| Asset Management Ii Lp Mpm | 10% | — | 1 | $168K | 2008-04-16 |
| Luke Evnin | Dir10% | — | 1 | $168K | 2010-01-27 |
| David F. Hale | Dir | — | 1 | $23K | 2008-04-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jonathan P. Foster | CFO | Buy | $200K | 2025-06-23 |
| Walter V. Klemp | CEO & President | Buy | $500K | 2025-06-23 |
| Jonathan P. Foster | CFO | Buy | $20K | 2023-12-26 |
| Robert E. George | Director | Buy | $10K | 2023-12-26 |
| Walter V. Klemp | CEO & President | Buy | $260K | 2023-12-26 |
| Walter V. Klemp | CEO & President | Buy | $58K |
Companies that share insiders with MBRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-11-25 |
| Walter V. Klemp | President | Buy | $26K | 2022-11-21 |
| Walter V. Klemp | CEO & President | Buy | $191K | 2022-11-16 |
| Waldemar Priebe | 10% Owner | Sell | $170K | 2017-08-16 |
| Walter V. Klemp | CEO & 10% | Buy | $10K | 2017-05-11 |
| Jacqueline Northcut | Director | Buy | $820 | 2017-05-05 |
| Robert E. George | Director | Buy | $940 | 2017-04-28 |
| Jonathan P. Foster | President & VP | Buy | $9K | 2017-04-25 |
| Paul K. Laikind | CEO | Buy | $4K | 2008-11-18 |
| Asset Management Ii Lp Mpm | 10% | Buy | $168K | 2008-04-16 |